GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
40 hedge funds and large institutions have $42.1M invested in Genocea Biosciences, Inc. in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 41 → 40 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
40
Holding in Top 10
1
Calls
$712K
Puts
$84K
Top Buyers
| 1 | +$92.4K | |
| 2 | +$51.9K | |
| 3 | +$38.1K | |
| 4 |
Millennium Management
New York
|
+$20.2K |
| 5 |
Jane Street
New York
|
+$20.1K |
Top Sellers
| 1 | -$83.4K | |
| 2 | -$25K | |
| 3 | -$24K | |
| 4 |
VF
Virtu Financial
New York
|
-$15K |
| 5 |
Two Sigma Advisers
New York
|
-$13.8K |